Stanford University
Showing 2,211-2,220 of 37,044 Results
-
Michael Bassik
Associate Professor of Genetics
Current Research and Scholarly InterestsWe are an interdisciplinary lab focused on two major areas:(1) we seek to understand mechanisms of cancer growth and drug resistance in order to find new therapeutic targets(2) we study mechanisms by which macrophages and other cells take up diverse materials by endocytosis and phagocytosis; these substrates range from bacteria, viruses, and cancer cells to drugs and protein toxins. To accomplish these goals, we develop and use new technologies for high-throughput functional genomics.
-
Stefan Oliver Bassler
Postdoctoral Scholar, Biology
BioStefan is a Bridging Excellence Postdoctoral Fellow in the Petrov lab at Stanford University and in the Aulehla & Steinmetz labs at EMBL (2025-now). He is fascinated by how evolution can be used to probe the genomic plasticity of biological systems. During his PhD with Nassos Typas at EMBL supported by the Joachim Herz Add-on Fellowship, he mapped the Genomic landscape of resistance evolution by performing high-throughput resistance evolution of the genome-wide KO library in E. coli. He discovered that evolvability genes constrain resistance evolution through gene-gene and gene-gene-drug interactions. In his postdoctoral work, he will Assess the inter-kingdom conservation of lifespan variants evolved in yeast.
-
Pamela A. Basto
Instructor, Medicine - Oncology
BioDr. Basto is a physician scientist and medical oncologist specializing in the diagnosis and treatment of gastrointestinal malignancies.
She attended The University of Texas graduating magna cum laude in biomedical engineering, subsequently gaining her Ph.D. in Medical Engineering and Medical Physics at the Harvard-MIT Health Science and Technology program the under the tutelage of Professors Robert Langer and Ulrich von Andrian at the Koch Institute for Integrative Cancer Research. Her thesis focused on developing next generation polymeric nanoparticle vaccines towards improved antigen specific cellular and humoral responses, work that has been translated into clinical trials. She completed medical school at Stanford University, followed by residency in internal medicine at The Mount Sinai Hospital in the ABIM research pathway, where she served on the ICU frontlines during the COVID-alpha wave at Elmhurst Hospital. She subsequently completed her hematology/oncology fellowship at Stanford University training in Professor Edgar Engleman’s lab in tumor immunology. Her translational research studies how cancers metastasize leveraging the immune system and designing therapeutics to interrupt this cascade. She was clinically trained by Professor Lipika Goyal in clinical and trial management of patients with hepatopancreatobiliary cancers.
As a clinician, she aims to create a welcoming partnership with patients during a difficult diagnosis based in trust and science, supported by an excellent clinical team. She welcomes patients from all backgrounds and aims to honor their values in culture, religion, and gender preferences. Her approach is to offer evidence based knowledge and the latest available treatments, including clinical trials, personalized to each individual’s tumor biology and their values. -
Ashley S. Batchelder, MSN, APRN, FNP-BC
Affiliate, IT Services
BioAshley Batchelder, MSN, FNP-BC is an advanced practice provider in Advanced Heart and Lung Disease at Stanford Health Care. With over eight years of clinical practice, specializing in solid organ transplantation.
